ETS1 and head and neck squamous cell carcinoma: Our data demonstrated that, consistent with ETS-1 expression, cisplatin-resistant HNSCC cells (SCC25CP, Cal27CP and FaDu-CP cells) had higher levels of ETS-1 phosphorylation at T-38 compared to their parental cells (Fig. 5a).